Open Access Policy

The Journal of Pharmaceutical, Biomedical and Chemistry Research (JPBCR) is a peer-reviewed, open-access journal. All manuscripts published after peer review by JPBCR are available to readers free of charge. The sanctioned manuscripts are available to the public without limitations or the necessity for registration.

The authors retain the copyright of the publication and are authorized to distribute the work without restrictions. Scholars can utilize these manuscripts to further their research or academic pursuits.

An individual (e.g., author, reader, reviewer, editor, or any other person) may read, download, copy, distribute, print, search, or link to the whole texts of these articles or employ them for any other lawful purpose.

Writers must pay an Article Processing Charge (APC) to cover expenses related to website maintenance, editing, and other fees. The Article Processing Charge (APC) is payable solely upon the manuscript's approval after a comprehensive peer review procedure.

The Journal of Pharmaceutical, Biomedical and Chemistry Research (JPBCR) seeks to abolish fees that might obstruct the dissemination of significant research. JPBCR manages a fund to waive costs for writers from developing countries whose universities or institutions lack the financial resources to pay, or who have not received sufficient support from funding agencies.

JPBCR fervently promotes and supports unrestricted access to all knowledge resources. We comply with the open access policies set out by the Open Access Scholarly Publishers Association (OASPA), the Directory of Open Access Journals (DOAJ), and the Budapest Open Access Initiative.

The Journal of Pharmaceutical, Biomedical and Chemistry Research (JPBCR) is offering a waiver on Article Processing Charges (APC) for submissions received until December 2025, providing researchers an opportunity to publish their work without incurring publication fees during this period.